{"id":"20220218cg67333","sourceId":"pr-newswire","sourceName":"PR Newswire","providerName":"PR Newswire","title":"Thinking about buying stock in Creative Medical Technology, Nu Holdings, Barrick Gold, Opendoor Technologies, or Karyopharm Therapeutics?","publishedDate":"2022-02-18T10:50:00-06:00","body":[{"type":"text","content":"Thinking about buying stock in Creative Medical Technology, Nu Holdings, Barrick Gold, Opendoor Technologies, or Karyopharm Therapeutics?\n\n\n\n\n\n","gated":false},{"type":"div","contentObject":[{"type":"text","content":"\n","gated":false},{"type":"h1","contentObject":[{"type":"text","content":"Thinking about buying stock in Creative Medical Technology, Nu Holdings, Barrick Gold, Opendoor Technologies, or Karyopharm Therapeutics?","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"PR Newswire","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"NEW YORK, Feb. 18, 2022","gated":false}],"gated":false}],"gated":false},{"type":"text","content":"\n\n","gated":false},{"type":"div","contentObject":[{"type":"text","content":"\n\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"NEW YORK, Feb. 18, 2022 /PRNewswire/ --  ","gated":false},{"type":"a","href":"https://c212.net/c/link/?t=0&l=en&o=3448839-1&h=2714728932&u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fprnumber%3D021820225&a=InvestorsObserver","contentObject":[{"type":"text","content":"InvestorsObserver","gated":false}],"gated":false},{"type":"text","content":" issues critical PriceWatch Alerts for CELZ, NU, GOLD, OPEN, and KPTI.","gated":false}],"gated":false},{"type":"text","content":"\n\n    ","gated":false},{"type":"div","contentObject":[{"type":"text","content":"\n                ","gated":false},{"type":"p","contentObject":[{"type":"text","content":"\n                        ","gated":false},{"type":"a","href":"https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.html","contentObject":[{"type":"text","content":"\n                    ","gated":false},{"type":"img","src":"https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg","alt":"InvestorsObserver (PRNewsfoto/InvestorsObserver)","variations":[],"gated":false},{"type":"text","content":"\n                        ","gated":false}],"gated":false},{"type":"text","content":"\n                ","gated":false}],"gated":false},{"type":"text","content":"\n\n    ","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"ul","contentObject":[{"type":"li","contentObject":[{"type":"text","content":"CELZ: ","gated":false},{"type":"a","href":"https://c212.net/c/link/?t=0&l=en&o=3448839-1&h=1264376852&u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DCELZ%26prnumber%3D021820225&a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DCELZ%26prnumber%3D021820225","contentObject":[{"type":"text","content":"https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=CELZ&prnumber=021820225","gated":false}],"gated":false},{"type":"text","content":" ","gated":false}],"gated":false},{"type":"li","contentObject":[{"type":"text","content":"NU: ","gated":false},{"type":"a","href":"https://c212.net/c/link/?t=0&l=en&o=3448839-1&h=3779760975&u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DNU%26prnumber%3D021820225&a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DNU%26prnumber%3D021820225","contentObject":[{"type":"text","content":"https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=NU&prnumber=021820225","gated":false}],"gated":false},{"type":"text","content":" ","gated":false}],"gated":false},{"type":"li","contentObject":[{"type":"text","content":"GOLD: ","gated":false},{"type":"a","href":"https://c212.net/c/link/?t=0&l=en&o=3448839-1&h=3848604696&u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DGOLD%26prnumber%3D021820225&a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DGOLD%26prnumber%3D021820225","contentObject":[{"type":"text","content":"https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=GOLD&prnumber=021820225","gated":false}],"gated":false},{"type":"text","content":" ","gated":false}],"gated":false},{"type":"li","contentObject":[{"type":"text","content":"OPEN: ","gated":false},{"type":"a","href":"https://c212.net/c/link/?t=0&l=en&o=3448839-1&h=2260843610&u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DOPEN%26prnumber%3D021820225&a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DOPEN%26prnumber%3D021820225","contentObject":[{"type":"text","content":"https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=OPEN&prnumber=021820225","gated":false}],"gated":false},{"type":"text","content":" ","gated":false}],"gated":false},{"type":"li","contentObject":[{"type":"text","content":"KPTI: ","gated":false},{"type":"a","href":"https://c212.net/c/link/?t=0&l=en&o=3448839-1&h=2793818069&u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DKPTI%26prnumber%3D021820225&a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-stocks-lp-2%2F%3Fsymbol%3DKPTI%26prnumber%3D021820225","contentObject":[{"type":"text","content":"https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=KPTI&prnumber=021820225","gated":false}],"gated":false},{"type":"text","content":" ","gated":false}],"gated":false}],"gated":false},{"type":"p","contentObject":[{"type":"text","content":"(Note: You may have to copy this link into your browser then press the [ENTER] key.)","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.","gated":false}],"gated":false},{"type":"text","content":"\n\n","gated":false},{"type":"div","contentObject":[{"type":"text","content":"\n","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"img","src":"https://c212.net/c/img/favicon.png?sn=CG67333&sd=2022-02-18","alt":"Cision","variations":[],"gated":false},{"type":"text","content":" View original content to download multimedia:","gated":false},{"type":"a","href":"https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-creative-medical-technology-nu-holdings-barrick-gold-opendoor-technologies-or-karyopharm-therapeutics-301485792.html","contentObject":[{"type":"text","content":"https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-creative-medical-technology-nu-holdings-barrick-gold-opendoor-technologies-or-karyopharm-therapeutics-301485792.html","gated":false}],"gated":false}],"gated":false},{"type":"text","content":"\n","gated":false},{"type":"p","contentObject":[{"type":"text","content":"SOURCE  InvestorsObserver","gated":false}],"gated":false},{"type":"text","content":"\n","gated":false}],"gated":false}]}